Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EQS-Adhoc: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.


EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Regulatory Approval
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.

23-Apr-2024 / 15:56 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.

Today, Redcare Pharmacy has received approval to implement its eHealth-CardLink solution from the German national agency for digital medicine, gematik. This will enable Redcare Pharmacy to offer patients in Germany a user-friendly method to redeem e-prescriptions by using their electronic health card and their mobile phone.  

The eHealth-CardLink solution is expected to be available in Redcare Pharmacy´s German Shop Apotheke app by early May.

 

 

 




Contact:
rikutis consulting
Thomas Schnorrenberg
Cel: +49 151 46 53 13 17
E-Mail: [email protected]


End of Inside Information

23-Apr-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: [email protected]
Internet: www.redcare-pharmacy.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y072
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1887349

 
End of Announcement EQS News Service

1887349  23-Apr-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1887349&application_name=news&site_id=sharewise~~~202ee175-2c72-4a50-a0f7-89cd8fcfa533

Shop Apotheke Europe NV Stock

€128.60
2.230%
There is an upward development for Shop Apotheke Europe NV compared to yesterday, with an increase of €2.80 (2.230%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Shop Apotheke Europe NV.
With a target price of 154 € there is a slightly positive potential of 19.75% for Shop Apotheke Europe NV compared to the current price of 128.6 €.
Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments